# 3 Acylamino 2 oxo 1 azetidinyl oxy methyl phosphinic acids.

## Abstract
Antibacterial activity is exhibited by β lactams having a 3 acylamino substituent and in the 1 position a substituent having the formula

## Claims
What is claimed is 1. A compound having the formulaEMI47.1 or a pharmaceutically acceptable salt thereof. wherein R1 is acyl R2 is hydrogen or methoxy R3 and R4 are the same or different and each is hydrogen, alkyl. alkenyl. alkynyl. cycloalkyl, phenyl, substituted phenyl or a 4,5,6 or 7 membered heterocycle or one of R3 and R4 is hydrogen and the other is azido, halomethyl, dihalomethyl, trihalomethyl, alkoxycarbonyl. alkenyl. alkynyl. 2 phenylethenyl, 2 phenylethynyl. carboxyl. CH2X1. S X2. O X2, EMI47.2 whereinX1 is azido, amino. hydroxy, alkanoylamino, phenylcarbonylamino, substituted phenyl carbonyl amino. alkylsulfonyloxy, phenylsulfonyloxy. substituted phenyl0sulfonyloxy. phenyl. substituted phenyl, cyano,EMI47.3 or O X2 X is alkyl. substituted alkyl, phenyl. substituted phenyl, phenylalkyl. substituted phenyl alkyl. alkanoyl. phenylalkanoyl, substitued phenyl alkanoyl. phenylcarbonyl, substituted phenyl carbonyl, or heteroarylcarbonyl one of X3 and X4 is hydrogen and the other is hydrogen or alkyl, or X3 and X4 when taken together with the carbon atom to which they are attached form a cycloalkyl group X5 is formed. alkanoyl. phenylcarbonyl, substituted phenyl carbonyl, phenylalkylcarbonyl, substituted phenyl alkylcarbonyl. carboxyl, alkoxycarbonyl, aminocarbonyl, substituted amino carbonyl, or cyano A is CH CH . cH2 n , CH2 O . or CH S CH n is O. 1 or 2 andX6 and t7 are the same or different and each is hydrogen, alkyl, phenyl or substituted phenyl, or X6 is hydrogen and X7 is amino. substituted amino. acylamino or alkoxy. or X6 and Z7 when taken together with the nitrogen atom to which they are attached form a 4, 5, 6 or 7 membered heterocycle R5 and R6 are the same or different and each is hydrogen, alkyl, alkenyl. alkynyl. phenyl. substituted phenyl. cycloalkyl or a 4.5,6 or 7 membered heterocycle, or R5 and R6 together with the carbon atom to which they are attached are cycloalkyl or a 4,5.6 or 7 membered heterocycle, or one of R5 and R6 is hydrogen and the other is azido. halomethyl. dihalomethyl, trihalomethyl, alkoxycarbonyl. alkenyl, alkynyl, 2 phenylethenyl. 2 phenylethynyl, carboxyl. CH2Xl, S X2. EMI48.1 R7 is hydrogen. alkyl. substituted alkyl, phenyl, substituted phenyl. l ethoxycarbonyl oxy ethyl, 1,3 dihydro 3 oxo l isobenzofuranyl,EMI49.1 wherein R is hydrogen or alkyl, R is alkyl or phenyl. R is hydrogen, methyl or phenyl, andRiV is hydrogen or together with Rt is CH2 3 or CH2 5 and R8 is hydroxy. alkoxy. substituted alkyl oxy, phenyloxy, substituted phenyl oxy. alkyl. substituted alkyl. phenyl, substituted phenyl, heteroaryl. amino. substituted amino. alkylthio. substituted alkyl thio. phenylthio. substituted phenyl thio, orEMI49.2 2. A compound in accordance with claim 1 wherein R2 is hydrogen. 3. A compound in accordance with claim 1 wherein R3 and R4 are the same or different and each is hydrogen or alkyl. 4. A compound in accordance with claim 2 wherein R3 and R4 are the same or different and each is hydrogen or alkyl. 5. A compound in accordance with claim 1 wherein R5 and R6 are the same or different and each is hydrogen or alkyl. 6. A compound in accordance with claim 2 wherein R5 and R6 are the same or different and each is hydrogen or alkyl. 7. A compound in accordance with claim 1 wherein R7 is hydrogen or alkyl and R8 is hydroxy or alkoxy. 8. A compound in accordance with claim 2 wherein R7 is hydrogen or alkyl and R 8 is hydroxy or alkoxy 9. A compound in accordance with claim 1 wherein R2 is hydrogen R3 and R4 are the same or different and each is hydrogen or alkyl R5 and R6 are the same or different and each is hydrogen or alkyl R7 is hydrogen or alkyl and R8 is hydroxy or alkoxy. 10. A compound in accordance with claim 1. 3S 3 alpha Z ,4ss 3 2 amino 4 thiazolyl metylxyimino acetyl amino 4 methyl 2oxo 1 azetidinyl oxy methyl phosphonic acid. or a salt thereof. 11. A compound in accordance with claim 1, 3S 3 alpha Z ,4ss 3 2 Amino 4 thiazolyl metylxyimino acetyl amino 4 methyl 2oxo 1 azetidinyl oxy methyl phosphonci acid. methyl ester. or a salt thereof. 12. A compound in accordance with claim I. 3S 3 alpha Z ,4ss 3 2 Amino 4 thiazolyl metylxyimino acetyl amino 4 methyl 2oxo 1 azetidinyl oxy methyl phosphonic acid, diethyl ester or a salt thereof. 13. A compound in accordance with claim 1. 3S 3 alpha Z ,4ss 3 2 Amino 4 thiazolyl metylxyimino acetyl amino 4 methyl 2 oxo 1 azetidinylloxylmethyllmethylphosphinic acid. or a salt thereof. 14. A compound having the formulaEMI51.1 wherein R3 and R4 are the same or different and each is hydrogen, alkyl. alkenyl. alkynyl. cycloalkyl, phenyl, substituted phenyl or a 4,5,6 or 7 membered heterocycle or one of R3 and R4 is hydrogen and the other is azido. halomethyl. dihalomethyl, trihalomethyl, alkoxycarbonyl. alkenyl, alkynyl. 2 phenylethenyl. 2 phenylethynyl. carboxyl, CH2 18 a SX2a O X2. EMI51.2 whereinX1 is azido. amino. hydroxy, alkanoylamino, phenylcarbonylamino. substituted phenyl carbonylamino. alkylsulfonyloxy, phenylsulfonyloxy, substituted phenyl sulfonyloxy. phenyl, substituted phenyl, cyano.EMI51.3 or O X2 X2 is alkyl, substituted alkyl. phenyl. substituted phenyl. phenylalkyl. substituted phenyl alkyl. alkanoyl. phenylalkanoyl, substitued phenyl alkanoyl. phenylcarbonyl, substituted phenyl carbonyl, or heteroarylcarbonyl one of X3 and X4 is hydrogen and the other is hydrogen or alkyl. orX3 and X4 when taken together with the carbon atom to which they are attached form a cycloalkyl group X5 is formyl, alkanoyl. phenylcarbonyl. substituted phenyl carbonyi. phenylalkylcarbonyl. substituted phenyl alkylcarbonyl, carboxyl, alkoxycarbonyl, aminocarbonyl. substituted auino carbonyl, or cyano A is CH CH , CH2 n . CH2 O . CH2 NH or CH2 S CH2 n is 0. 1 or 2 and X6 and X7 are the same or different and each is hydrogen. alkyl. phenyl or substituted phenyl, or X6 is hydrogen and X7 is amino, substituted amino, acylamino or alkoxy. or X6 and X7 when taken together with the nitrogen atom to which they are attached form a 4. 5. 6 or 7 membered heterocycle R5 and R6 are the same or different and each is hydrogen. alkyl. alkenyl. alkynyl. phenyl, substituted phenyl. cycloalkyl or a 4.5.6 or 7 membered heterocycle, or R5 and R6 together with the carbon atom to which they are attached are cycloalkyl or a 4.5.6 or 7 membered heterocycle. or one of R5 and R6 is hydrogen and the other is azido. halomethyl. dihalomethyl. trihalomethyl, alkoxycarbonyl, alkenyl. alkynyl. 2 phenylethenyl, 2 phenylethynyl, carboxyl, CH2X1. S X2, EMI52.1 R7 is hydrogen, alkyl. substituted alkyl. phenyl. substituted phenyl. l ethoxycarbonyloxy ethyl. 1.3 dihydro 3 oxo l isobenzofuranyl.EMI52.2 wherein R is hydrogen or alkyl, RZ is alkyl or phenyl. R is hydrogen. methyl or phenyl. and Riv is hydrogen or together with R is or CH2 5 and R8 is hydroxy. alkoxy, substituted alkyl oxy, phenyloxy, substituted phenyl oxy. alkyl. substituted alkyl. phenyl, substituted phenyl, heteroaryl. amino. substituted amino, alkylthio. substituted alkyl thio. phenylthio, substituted phenyl thio.EMI53.1

## Description
Antibacterial activity is exhibited by fl lactams having the formulaEMI1.1 and pharmaceuticallytacceptable salts thereof As used in formula I, and throughout the specification, the symbols are as defined below. R1 is acyl R2 is hydrogen or methoxy R3 and R4 are the same or different and each is hydrogen, alkyl alkenyl, alkynyl.cycloalkyl, phenyl. substituted phenyl or a 4,5,6 or 7 membered heterocycle refetred to hereinafter as R9 or one of R3 and R4 is hydrogen and the other is azido. halomethyl, dihalomethyl, trihalomethyl, alkoxyearbonyl, alkenyl. alkynyl. 2 phenylethenyl. 2 phenylethynyl. carboxyl, CH2X1 wherein X1 is azido. amino NK2 , hydroxy. alkanoylaminol. phenylcarbonylamino. substituted phenyl carbonylamino. alkylsulfonyloxy, phenylsulfonyloxy, substituted phenyl sulfonyloxy, phenyl. substituted phenyl, cyano,EMI1.2 S Xz, or O X2 wherein A.X2. X6 and X7 are as hereinafter defined J. S Xz or O X2 twherein X2 is alkyl.substituted alkyl. phenyl. substituted phenyl.phenylalkyl. substituted phenyl alkyl. alkanoyl.phenylalkanoyl, substituted phenyl alkanoyl.phenylcarbonyl. substituted phenyl carbonyl. or heteroarylcarbonyl , EMI2.1 wherein one of X3 andX4 is hydrogen and the other is hydrogen or alkyl. or X3 and X4 when taken together with the carbon atom to which they are attached form a cycloalkyl group and X5 is formyl, alkanoyl.phenylcarbonyl, substituted phenyl carbonyl. phenylalkylcarbonyl. substituted phenyl alkylcarbonyl. carboxyl. alkoxycarbonyl.aminocarbonylEMI2.2 substituted amino carbonyl. or cyano C N 1, orEMI2.3 wherein A is CH CW. CH2 n . CH2 O . CH2 NH . or CH2 S CH2 . n is 0. 1 or 2. andX6 and X7 are the same or different and each is hydrogen. alkyl. phenyl or substituted phenyl. orX6 is hydrogen and X7 is amino. substituted amino. acylamino or alkoxy. or X6 and K when taken together with the nitrogen atom to which they are attached form a 4. 5. 6 or 7 membered heterocycle R5 and R6 are the same or different and each is hydrogen, alkyl. alkenyl, alkynyl. phenyl.substituted phenyl, cycloalkyl or R9. or R5 andR6 together with the carbon atom to which they are attached are cycloalkyl or R9. or one of R5 and R6 is hydrogen and the other is azido.halomethyl. dihalomethyl. trihalomethyl, alkoxycarbonyl. alkenyl. alkynyl. 2 phenylethenyl, 2 phenylethynyl. carboxyl. Ch2X1. S X2. EMI2.4 R7 is hydrogen, alkyl1 substituted alkyl.phenyl. substituted phenyl. l ethoxyearbonyloxy ethyl, l,3 dihydro 3 oxo l isobenzofuranyl, EMI3.1 wherein R is hydrogen or alkyl. R is alkyl or phenyl. R is hydrogen. methyl or phenyl and Riv is hydrogen or together with R is CH2 3 or CH2 5 and R8 is hydroxy. alkoxy. substituted alkyl oxy, phenyloxy. substituted phenyl oxy. alkyl.substituted alkyl. phenyl, substituted phenyl.heteroaryl. amino. substituted amino. alkylthio. substituted alkyl thio. phenylthio, substituted phenyl thio, orEMI3.2 Listed below are definitions of various terms used to describe the ss lactams of this invention.These definitions apply to the terms as they are used throughout the specification unless they are otherwise limited in specific instances either individually or as part of a larger group. The terms alkyl and alkoxy refer to both straight and branched chain groups. Those groups having 1 to 10 carbon atoms are preferred. The terms cycloalkyl and cycloalkenyl refer to cycloalkyl and cycloalkenyl groups having 3,4.5,6 or 7 carbon atoms. The term substituted alkyl refers to alkyl groups substituted with one. or more. azido. amino NH2 a halogen. hydroxy, carboxy. cyano, alkoxycarbonyl. aminocarbonyl. alkanoyloxy. alkoxy.phenyloxy. substituted phenyl oxy. Rg oxy, mercapto. alkylthio. phenylthio. substituted phenyl thio. alkylsulfinyl. or alkylsulfonyl gruops. The terms alkanoyl . alkenyl . and alkynyl refer to both straight and branched chain groups. Those groups having 2 to 10 carbon atoms are preferred. The tetms halogen and halo refer to fluorine. chlorine. bromine and iodine. The term substituted phenyl refers to a phenyl group substituted with 1. 2 or 3 amino NH2 . halogen. hydroxyl. trifluoromethyl.alkyl of 1 to 4 carbon atoms . alkoxy of 1 to 4 carbon atoms . carbamyl. or carboxyl groups. The expression a 4.5,6 or 7 membered heterocycle referred to as wRgn refers to substituted and unsubstituted. aromatic and nonaromatic groups containing one or more nitrogen.oxygen or sulfur atoms. Exemplary substituents are oxo O . halogen. hydroxy nitro, amino. cyano.trifluoromethyl. alkyl of 1 to 4 carbons, alkoxy of 1 to 4 carbons. alkylsulfonyl. phenyl. substituted phenyl. 2 furyliminoEMI4.1 benzylimino and substituted alkyl groups wherein the alkyl group has l to 4 carbons . One type of 4.5.6 or 7 membered heterocycle is the Wheteroaryl group.The term heteroaryl refers to those 4.5,6 or 7 membered heterocycles which are aromatic. Exemplary heteroaryl groups are substituted and unsubstituted pyridinyl, furanyl, pyrrolyl, thienyl, 1,2,3, triazolyl. 1,2,4 triazolyl.imidazolyl, thiazolyl. thiadiazolyl. pyrimidinyl, oxazolyl, triazinyl, and tetrazolyl. Exemplary nonaromatic heterocycles i.e., fully or partially saturated heterocyclic groups are substituted and unsubstituted azetinyl, oxetanyl. thietanyl, piperidinyl. piperazinyl. imidazolidinyl, oxazolidinyl. pyrrolidinyl, tetrahydropyrimidinyl.dihyrothiazolyl and hexahydroazepinyl. Exemplary of the substituted 4.5.6 or 7 membered heterocycles are l alkyl 3 azetinyl, 2 oxo l imidazolidinyl, 3 alkylsulfonyl 2 oxo l imidazolidinyl.3 benzylimino 2 oxo l imidazolidinyl. 3 alkyl2 oxo l imidazolidinyl, 3 phenyl or substitutd phenyl 2 oxo l imidazolidinyl, 3 benzyl 2 oxol imidazolidinyl, 3 2 aminoethyl 2 oxo limidazolidinyl, 3 amino 2 oxo 1 imidazolidinyl, 3 alkoxycarbonyl aminoi 2 oxo l imidazolidinyl. 3 2 alkoxycarbonyl amino ethyl 2 oxo 1 imidazolidinyl. 2 oxo l pyrrolidinyl. 2 oxo 3oxazolidinyl, 4 hydroxy 6 methyl 2 pyrimidinyl. 2 oxo l hexahydroazepinyl, 2 oxo 3 pyrrolidinyl.2 oxo 3 furanyl. 2,3 dioxo l piperazinyl, 2,5 dioxo 1 piperazinyl. 4 alkyl 2,3 dioxo l piperazinyl. and 4 phenyl 2,3 dioxo l piperazinyl. The term substituted amino refers to a group having the formula NY1Y2 wherein Y1 is hydrogen, alkyl. phenyl, substituted phenyl, phenylalkyl or substituted phenyl alkyl, and is alkyl, phenyl, substituted phenyl. phenylalkyl. substituted phenyl alkyl. hydroxy, cyano. alkoxy.phenylalkoxy, or amino The term acyl refers to all organic radicals derived from an organic acid i.e., a carboxylic acid by removal of the hydroxyl group. Certain acyl groups are, of course, preferred but this preference should not be viewed as a limitation of the scope of this invention Exemplary acyl groups are those acyl groups which have been used in the past to acylate B lactam antibiotics including 6 aminopenicillanic acid and derivatives and 7 aminocephalosporanic acid and derivatives see, for example, Cephalosporins and Penicillins, edited by Flynn, Academic Press 1972 , GermanOffenlegungsschrift 2,716,677, publishedOctober 10, 1978, Belgian patent 867,994, published December 11, 1978, United States patent 4,152,432, issued May 1, 1979, UnitedStates patent 3,971,778, issued July 27, 1976,United States patent 4,172,199, issued October 23, 1979, and British patent 1 348,894, publishedMarch 27, 1974. The portions of these references describing various acyl groups are incorporated herein by reference. The following list of acyl groups is presented to further exemplify the term acyl it should not be regarded as limiting that term.Exemplary acyl groups are a Aliphatic groups having the formulaEMI6.1 wherein Ra is alkyl cyclcr.lkyl alkoxy alkenyl cycloalkenyl cyclohexadienyl or alkyl or alkenyl substituted with one or more halogen, cyano, nitro, amino, mercapto, alkylthio, or cyanomethylthio groups. b Carbocyclic aromatic groups having the formulaEMI7.1 EMI8.1 wherein n is 0, 1, 2 or 3 Rb, Rct and Rd each is independently hydrogen, halogen, hydroxyl, nitro, amino, cyano, trifluoromethyl, alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms or aminomethyl and Re is amino, hydroxyl, a carboxyl salt, protected carboxyl, formyloxy, a sulfo salt, a sulfoamino salt, azido, halogen, hydrazino, alkyihydrazino, phenylhydrazino, or r alkylthio thioxomethyli thio. Preferred carbocyclic aromatic acyl groups include those having the formulaEMI8.2 EMI9.1 Re is preferably a carboxyl salt or sulfo salt andEMI9.2 Re is preferably a carboxyl salt or sulfo salt . c Heteroaromatic groups having the formulaEMI9.3 wherein n is 0, 1, 2 or 3 Re is as defined above and Rf is a substituted or unsubstituted 5 , 6 or 7 membered heterocyclic ring containing 1,2,3 or 4 preferably 1 or 2 nitrogen, oxygen and sulfur atoms.Exemplary heterocyclic rings are thienyl, furyl, pyrrolyl, pyridinyl, pyrazolyl, pyrazinyl, thiazolyl, pyrimidinyl, thiadiazolyl and tetrazolyl Exemplary substituents are halogen, hydroxyl, nitro, amino, protected amino, cyano, trifluoromethyl, alkyl of 1 to 4 carbon atoms, alkoxy of I to 4 carbon atoms, orEMI10.1 Preferred heteroaromatic acyl groups include those groups of the above formulas wherein Rf is 2 amino 4 thiazolyl, 2 amino 5 halo 4 thiazolyl, 4 aminopyrimidin 2 yl, 5 amino 1,2,4 thiadiazol 3 yl, 2 thienyl, 2 furanyl, or 6 aminopyridin 2 yl. d 4 Substituted 2,3 dioxo 1 piperazinyl carbonyl amino arylacetyl groups having the formulaEMI10.2 wherein R is an aromatic group including g carbocyclic aroma tics such as those of the formulaEMI10.3 and heteroaromatics as included within the definition of Rf and Rh is alkyl, substituted alkyl wherein the alkyl group is substituted with one or more halogen, cyano, nitro, amino or mercapto groups , arylmethyleneamino i.e., N CH Rg wherein Rg is as defined above , arylcarbonylamino i.e., EMI11.1 wherein Rg is as defined above or alkylcarbonylamino. Preferred 4 substituted 2 ,3 dioxo 1 piperazinyl carbonylaamino arylacetyl groups include those wherein Rh is ethyl, phenylmethyleneamino or 2 furylmethyleneamino. e Substituted oxyimino arylacetyl groups having the formulaEMI11.2 wherein Rg is as defined above and Ri is hydrogen, alkyl, cycloalkyl alkylaminocarbonyl, arylamino carbonyl i.e.,EMI11.3 wherein Rg is as defined above or substituted alkyl wherein the alkyl group is substituted with one or more halogen, cyano, nitro, amino, mercapto, alkylthio, aromatic group as defined by Rg , carboxyl including salts thereof , amido, alkoxycarbonyl, phenylmethoxycarbonyl, diphenylmethoxycarbonyl, hydroxyalkoxyphosphinyl, dihydroxyphosphinyl, hydroxy phenylmethoxy phosphinyl, or dialkoxyphosphinyl substituents . Preferred substituted oxyimino arylacetyl groups include those wherein Rg is 2 amino 4 thiazolyl. Also preferred are those groups wherein Ri is methyl, ethyl, carboxymethyl, 1 carboxy 1 methylethyl, 2,2,2 trifluoroethyl or 1 carboxycyclopropyl. f Acylanino arylacetyl groups having the formulaEMI12.1 wherein Rg is as defined above and Rj isEMI12.2 amino, alkylamino, cyanoalkyl amino, amido, alkylamido, cyanoalkyl amido,EMI12.3 Preferred acylamino arylacetyl groups of the above formula include those groups whereinRj is amino or amido. Also preferred are those groups wherein R is phenyl or 2 thienyl. g g 3 Substituted 2 oxo 1 imidazoli dinyl carbonyl amino arylacetyl groups having the formulaEMI13.1 wherein Rg is as defined above and Rk is hydrogen, alkylsulfonyl, arylmethyl eneamino i.e., N CH R wherein Rg is as defined above ,EMI13.2 where in Rm is hydrogen, alkyl or halogen substituted alkyl , aromatic group as defined by Rg above , alkyl or substituted alkyl wherein the alkyl group is substituted with one or more halogen, cyano, nitro, amino or mercapto groups . Preferred 3 substituted 2 oxo l imidazoli dinyl carbonyl amino arylacetyl groups of the above formula include those wherein Rg is phenyl or 2 thienyl. Also preferred are those groups wherein Rk is hydrogen, methylsulfonylr phenylmethyleneamino or 2 furylmethyleneamino. The compounds of this invention form basic salts with various inorganic and organic bases which are also within the scope of this invention.Such salts include ammonium salts. alkali metal salts. alkaline earth metal salts. salts with organic bases. e.q. dicyclohexylamine. benzathine. N methyl D glucarnine. hydrabamine and the like.The pharmaceutically acceptable salts are preferred. although other salts are also useful. e.a., in isolating or purifying the product. Some of the compounds of this invention may be crystallized or recrystallized from solvents containing water. In these cases water of hydration may be formed. This invention contemplates stoichiometric hydrates as well as compounds containing variable amounts of water that may be produced by processes such as lyophilization. B Lactams having anEMI14.1 substituent in the l position and an amino or acylamino substituent in the 3 position contain at least one chiral center the carbon atom in the 3 position of the B lactam nucleus to which the amino or acylamino substituent is attached. This invention is directed to those B lactams which have been described above, wherein tbj stereochemistry at the chiral center in the 3 position of the ss lactam nucleus is the same as the configuration at the carbon atom in the 6 posi ion of naturally occurring penicillins te.a., pen.cillin G and as the configuration at the carbon om in the 7 position of naturally occurring cephamycins e.q.. cephamycin C . Also included within the scope of this invention are racemic mixtures which contain the above described 13 lactams. ss Lactams having anEMI15.1 substituent in the l position of the fl lactam nucleus and an acylamino substituent in the 3 position of the ss lactam nucleus have activity against a range of gram negative and gram positive organisms. The compounds of this invention can be used as agents to combat bacterial infections including urinary tract infections and respiratory infections in mammaliam species. such as domesticated animals e.a., dogs. cats, cows, horses. and the like and humans. For combating bacterial infections in mammals. a compound of this invention can be administered to a mammal in need thereof in an amount of about 1.4 mg kg day to about 350 mg kg day, preferably about 14 mgSkgOday to about 100 mg kg day. All modes of administration which have been used in the past to deliver penicillins and cephalosporins to the site of the infection are also contemplated for use with the novel family of ss lactams of this invention. Such methods of administration include oral, intravenous.intramuscular. and as a suppository. The B lactams of this invention can be prepared from an amino acid having the formulaEMI16.1 The amino group is first protected with a classical protecting group e.g.1 t butoxycarbonyl.benzyloxycarbonyl. 2 nitrophenylsulfenyl. etc. .yielding a compound having the formulaEMI16.2 In formula III. and throughout the specification.the symbol A1 refers to a nitrogen protecting group. The carboxyl group of a protected amino acid of formula III is then reacted with an amine salt having the formulaEMI16.3 In formula IV, and throughout the specification.the symbol XYZ refers to benzyl. pivaloyl, CH2 CH NHA2 CO2alkyl A2 is an amino protecting group , t butyl, p nitrobenzyl.benzhydryl. 2 cyanoethyl. 2 trimethylsilylethyl. trichloroethyl. E anisyl. inter alia. The reaction proceeds in the presence of a coupling agent such as 1 ethyl 3 3 dimethylaminopropyl carbociimide or dicyclohexylcarbodiimide, and yields a copound having he formula EMI17.1 The hydroxyl group of a compound of formula V is converted to a leaving group, using. for example, a classicai reagent such as methanesulfonyl chloride methanesulfonyl is referred to hereinafter as MS . The fully protected compound having the formulaEMI17.2 is cyclized by treatment with base, e.s., potassium carbonate. The reaction is preferably carried out in an organic solvent such as acetone, under reflux conditions. and yields a compound having the formulaEMI17.3 Alternatively. cyclization of a compound of formula V can be accomplished without first converting the hydroxyl group to a leaving group.Treatment of a compound of formula V with triphenylphosphine and diethylazodicarboxylate or carbon tetrachloride. yields a compound of formulaVII. Both of the methods disclosed above for ring closure of a compound of formula V result in the inversion of the stereochemistry of the R3 andR4 substituents. Selective reduction of a compound of formulaVII using catalytic hydrogenation if Y is benzyl or by treatment with a base such as sodium sulfide or sodium hydroxide if Y is pivaloyl, or with DBU if Y is CH2CH NHZ2 CO2alky1 yields the corresponding compound having the formulaEMI18.1 Compounds of formula VIII are described in copending United States patent application serial number 404.945. filed August 4. 1982 and some are also described in J.A.C.S.. 102 7to26 1980 . Alkylation of a hydroxanic acid of formulaVIII with an activated form of a compound having the formulaEMI18.2 can be accomplished by first generating the anion of the hydroxamic acid with a suitable base. and then reacting the resulting compound with an activated form of an acetic acid derivative of formula fX. Activated and protected forms of compounds of formula IX have the formulaEMI18.3 wherein Y is a suitable leaving group. such as a triflate group, or other reactive leaving group well known in the art. The above alkylation procedure has been described as a two step sequence, but both steps can be performed simultaneously. The resulting product has the formulaEMI19.1 Deprotection of the 3 amino substituent of a compound of formula X can be accomplished using art recognized techniques. If, for example. the protecting group is t butoxycarbonyl, trifluoroacetic acid can be used to deprotect the amino group. If the protecting group is benzyloxycarbonyl, catalytic e,q., palladium on charcoal hydrogenation can be used. If the protecting group is o nitrophenylsulfenyl. toluenesulfonic acid can be used in combination with E thiocresol. The deprotected compound has the formulaEMI19.2 and is a key intermediate for preparing the compounds of this invention. The compounds of formula XI form an integral part of this invention. Well known acylation techniques can be used to convert a compound of formula XI to the corresponding compound having the formulaEMI20.1 Exemplary techniques include reaction with a carboxylic acid R1 OE or corresponding carboxylic acid halide or carboxylic acid anhydride. The reactions with a carboxylic acid proceed most readily in the presence of a carbodiimide such as dicyclohexylcarbodiimide and a substance capable of forming a reactive intermediate in situ such as N hydroxybenzotriazole or 4 dimethylaminopyridine. In those instances wherein the acyl group R1 contains reactive functionality such as amino or carboxy groups it may be necessary to first protect these functional groups. then carry out the acylation reaction. and finally deprotect the resulting product. Alternatively. the compounds of this invention can be prepared by reacting a compound of formula III with an amine having the formulaEMI20.2 The reaction proceeds in the presence of a coupling agent such as dicyclohexylcarbodiimide and yields a compound having the formula EMI21.1 The amine of formula XIIf can be prepared by reacting N hydroxyphthalimide with an alcohol having the formulaEMI21.2 under Mitsunobu conditions triphenylphosphinediethyldiazodicarboxylate or with an activated form of the alcohol having the formulaEMI21.3 to yield a compound having the formulaEMI21.4 Cleavage of the phthalimide group in a compound of formula XVT with hydrazine or an alkylhydrazine yields the corresponding amine of formula XI II. A compound of formula XIV can be cyclized to give a compound of formula X using the procedures described above for the cyclization of a compound of formula VI. Those compounds of formula XII wherein R7 is alkyl and R8 is alkoxy can be coverted to the corresponding diacid having the formula EMI22.1 providing another route for the preparation of the products of formula I wherein is hydrogen and R8 is hydroxyl. Conversion to the diacid can be accomplished using trimethylsilyl bromide in the presence of bis trimethylsilylacetamide as a drying agent and acid scavenger, and then solvolyzing the resulting bis silyl ester with water or an alcohol. Those compounds of formula XII wherein N is alkyl and R8 is alkoxy can be heated with thiourea to yield the corresponding monoacid having the formulaEMI22.2 providing another route for the preparation of the products of formula I wherein R7 is hydrogen andR8 is alkoxy. Alternatively, mono acidic phosphorous derivatives can be obtained from the corresponding monoalkyl esters of formula XII. wherein R8 is alkyl. substituted alkyl. phenyl. substituted phenyl. heteroaryl. amino. or substituted amino. this subgrouping is referred to hereinafter asR10 . by treatment with an acid scavenger and drying agent such as bis trimethylsilylacetamide followed by treatment with trimethylsilyl bromide to yield an intermediate silyl ester having the formula EMI23.1 An intermediate of formula XIX can be treated with an organic or inorganic base in the presence of water or an alcohol to yield a salt of a compound having the formulaEMI23.2 The tetraalkylammonium salt of a compound of formula XX can be treated with an alkyl halide. substituted alkyl halide, l ethoxycarbonyloxy ethyl halide, 1,3 dihydro 3 oxo 1 isobenzofuranyl EMI23.3 EMI23.4 to obtain an ester having the formulaEMI23.5 wherein R11 is alkyl, substituted alkyl. 1 ethoxycarbonyloxy ethyl. 1.3 dihydro 3 oxo r isobenzofuranyl,EMI24.1 EMI24.2 When R10 is methoxy or ethoxy i.e.. a compound of formula XVIII. this process results in transesterification. yielding the tetraalkylammonium salt of a compound having the formulaEMI24.3 A compound of formula XXII can be converted to the corresponding compound of formula XXI wherein R10 is methoxy or ethoxy by treating the tetraalkylammonium salt of the compound of formulaXXII with methyl or ethyl sulfate. Alternatively.the tetraalkylammonium salt of the compound of formula XXII can be converted to the corresponding acid on ion exchange resin and then treated with diazomethane or diazoethane to yield the desired compond of formula XXII wherein R10 is methoxy or ethoxy. The products of formula I wherein R2 is methoxy can be prepared from the corresponding compound of formula VII. Halogenating preferably chlorinating the amide nitrogen of a compound of formula VII yields a compound having the formulaEMI25.1 Reagents and procedures of N chlorinating amides are known in the art. Exemplary reagents are tert. butyl hypochlorite. sodium hypochlorite, and chlorine. The reaction can be run in an organic solvent e.a.. a lower alkanoyl such as methanol or in a two phase solvent system e,s,, water methylene chloride in the presence of a base such as sodium borate decahydrate. The reaction is preferably run at a reduced temperature. Reaction of a compound of formula XXIII with a methoxylating agent. e.a., an alkali metal methoxide. yields a compound in combination with its enantiomer if R3 and R4 are the same or if XXIII is a racemic mixture having the formulaEMI25.2 The reaction can be run in an organic solvent, e.g.. a polar organic solvent such as tetrahydrofuran. at a reduced temperature. Alternatively, a compound of formula VII can be converted to a compound of formula XXIV using a single step procedure. The methoxylating agent can first be mixed with a compound of formula VII and the N chlorinating reagent then added to the reaction mixture. Conversion of a compound of formula XXIV to the desired products of formula I can be accomplished using the procedures described above for the conversion of an intermediate of formulaVII to a product of this invention. The following examples are specific embodiments of this invention. Example 1 3S 3 alpha Z , 4ss 3 2 Amino 4 thiazolyl methoxyimino acetyl amino 4 methyl 2 oxo 1 azetidinyl oxy methyl phosphonic acid a potassium saltA N Diethoxyphosphinyl methoxy Nê 1,1 dimethvlethoxy carbonyl l threoninamide To a solution of N t butoxycarbonylamino Lthreonine 3.20 g, 14.6 inmol in dimethylformamide 35 ml was added N hydroxybenzotriazole 1.97 g.14.6 mmol . The resulting solution was cooled to OOC, and dicyclohexylcarbodiimide 3.30 g, 16 mmolj was added. The ice bath was removed and the solution was stirred for thirty minutes at room temperature. After re cooling the solution to OOC. diethyl aminooxymethyl phosphonate 2.67 g. 14.6 mmol in dimethylformamide 25 ml was added. The solution was then stirred at room temperature for 16 hoursAfter removal of dimethylformamide at reduced pressure. the crude product 10.6 g was purified by two successive chromatographies on silica gel 40 acetone methylene chloride. and 33 acetone methylene chloride to afford 1.76 g of the title compound. B 3S trans 3 1.1 Dimethylethoxy carbonyl amino 4 methyl 2 oxo 1 azetidinyl oxy methyl phosphonic acid, diethyl ester N Diethoxyphosphinyl methoxy Nê 1.1dimethylethoxy carbonyl l thrsoninamide 1.38 g, 3.62 sol and triphenylphosphine 0.97 g, 3.7 mmol were placed in a round bottomed flask. which was dried in vacuo for thirty minutes at room temperature. Argon was introduced into the flask.followed by dry tetrahydrofuran 30 ml . The solution was cooled to 0 C and diethyfazodi carboxylate 585 pl, 3.7 mmol was added dropwise. The cooling bath was removed and the solution stirred at room temperature for 16 hours. Tetrahydrofuran was evaporated at reduced pressure, and the residue triturated with cold ether 30 ml. 10 C to precipitate triphenylphosphine oxide. Filtration and evaporation at reduced pressure afforded the crude product 1.96 g which was purified by chromatography on silica gel, eluting with 20 acetone methylene chloride.The product obtained in this manner is conveniently separated from the 4 hydroxy 4 methyl 2 pentanone aldol product by crystallization from ether pentane 1.l . The first crop of crystals thus obtained gave 0.61 g of the title compound.melting point 76 800C, Recrystallization from etherf pentane afforded the product. melting point 85 880C. C 3S 3 alpha Z , 4ss 3 2 Amino 4 thiazolyl methoxyimino acetyl amino 4 methyi 2 oxo l azetidinyl oxy methyl phosphonic acid, diethyl ester 3S trans 3 1.1 Dimethylethoxy carbonyl amino 4 methyl 2 oxo 1 azetidinyl oxy methyl phosphonic acid, diethyl ester 0.85 g. 2.32 mmol was weighed into a round bottomed flask under argon. and cooled to 10 C. A solution of 10 anisole in trifluoroacetic acid at 10 C was added.and the resulting solution was stirred at that temperature for thirty minutes. Evaporation of the volatiles at room temperature with a vacuum pump afforded the crude trifluoroacetic acid salt of the deprotected azetidone starting material which was used directly in the next step. The activated ester of Z 2 amino methoxyimino 4 thiazoleacetic acid was prepared by dissolving the acid 0.47 g. 2.32 mmol and hydroxy benzotriazole 0.31 g. 2.32 mmol in dimethylformamide 8 ml . This solution was cooled to OOC, and dicyclohexylcarbodiimide 0.48g. 2.3 mmol was added. The solution was stirred at room temperature for thirty minutes. and then cooled to OOC. To this solution of activated ester was added the trifluoroacetic acid salt prepared above, as a solution in dimethylformamide 2.5 ml . followed by two rinses of 2.5 ml and 1.0 ml of dimethylformamide. To this solution was added triethylamine 1.0 ml. 7.2 mmol . The pH was found to be ca. 9. and the ice bath was removed. After stirring for 16 hours at room temperature, dimethylformamide was evaporated in vacuo. The residue was treated with 5 ml of acetone. and solid potassium bicarbonate was added to adjust the pH to 6 on moist litmus paper. After filtering the solution to remove inorganic salts and hydroxybenzotriazole salt, the acetone solution was chromatographed on a reverse phase HP 20 column 25mm x 15 using 50 acetone water to elute 0.47 g of the title compound. melting point 74 780C.D 3S 3 alpha Z ,4ss 3 2 Amino 4 thiazolyl methoxyimino acetyl amino 4 methyl 2 oxo 1 azetidinyl3oxy3methyl3phosphonic acid. potassium salt 3S 3 alpha Z ,4ss 3 2 Amino 4 thiazolyl methoxyimino acetyl amino 4 methyl 2 oxo 1 azetidinyl oxy3methyl Iphosphonic acid, diethyl ester 0.10 g. 0.22 mmol was dissolved in dry methylene chloride 2.0 ml under argon and cooled to OOC. To this solution was added bis trimethylsilyl acetamide 0.20 m. 1.12 mmol and the solution was stirred for thirty minutes at OOC. Trimethylsilylbromide 0.20 ml. 1.5 mmol was added. and the cooling bath removed. Thin layer chromatography silica. 50 acetone methylene chloride showed no remaining starting material after 2.5 hours. and the volatiles were evaporated in wacuo, followed by azeotropic removal of residual trimethylsilyl bromide two times with 2 ml of toluene at low pressure. To the residue thus obtained was added pH 4.0 buffer 10 ml . followed by methylene chloride 10 ml . The mixture was stirred vigorously for fifteen minutes. and the aqueous layer separated.washed with methylene chloride 15 ml and lyophilized to afford the crude product 0.11 g which consisted predominantly of one spot by thin layer chromatography Rf 0.05, 3 1 1 n butanol water acetic acid . Chromatography on HP 20 25mm x 12 using water as the eluting solvent afforded the title compound. melting point 220 2250C. dec. Example 2 3S 3 alpha Z ,4ss 3 2 amino 4 thiazolyl methoxyimino acetyl amino 4 methyl 2 oxo 1azetidinyl oxy methyl phosphonic acid. methyl ester, Potasstua saltA 3S trams 3 1,1 Dimethylethoxy carbonyl amino q methyl 2 oxo 1 azetidinyl oxy methyl Phosphoric acid. dimethyl ester 3S trans 3 1,1 Dimethylethoxy carbonyl amino 4 methyl 2 oxo 1 azetidinyl oxy methyl phosphonic acid. diethyl ester 250 mg. 0.68 mmol was dissolved in dry methylene chloride 5 ml and cooled to 0 C under an argon atmosphere. Bis trimethylsilylacetamide 0.5 ml was added.After stirring for 15 minutes. trimethylsilyl bromide 0.5 ml was added to the solution. the ice bath removed. and the reaction mixture allowed to warm to room temperature over two hours. The volatiles were removed in vacuo, followed by azeotropic removal with toluene two times with ml . The crude phosphonate bis trimethylsilyl ester thus prepared was dissolved in dry ether 15 ml . and added to a stirring olution of diazomethane in ether methanol ca. 3 miol. ether methanol 20 ml 10 ml at 10 C. After stirring for fifteen minutes. three drops of acetic acid were added.which failed to further discharge the pale yellow color of the reaction mixture. The solvent was then removed at reduced pressure. affording 0.40 g of the crude title compound. The crude dimethyl phosphonate was purified by chromatography on silica gel 25 mm x 8 , eluting with 4 methanol ethyl acetate, yielding 170 mg of the title compound of sufficient purity to be used in the next step.B 3S trans 3 1,1 dimethylethoxy carbonyl amino 4 methjyl 2 oxo 1 azetidinyl oxy methyl Phosphonic acid, methvl ester. potassium salt 3S trans 3 1,1 dimethylethoxy carbonyl amino 4 methyl 2 oxo 1 azetidinyl oxy methyl phosphonic acid. dimethyl ester 170 mg. 0.50 mmol was dissolved in deuterated acetonitrile 2.5 ml .and thiourea 45 mg. 0.59 mmol was added. The mixture was heated in a sealed tube overnight at 800C. Chromatography on Dowex K 200 400 mesh, 25 mm x 6 , using water as the eluant, followed by lyophilization of the appropriate fractions afforded the title compound 70 mg .C 3S 3 alpha Z ,4ss 3 2 amino 4 thiazolyl methoxyimino acetyl amino 4 methyl 2 oxo 1 azetidinyl oxyjmethyliphosphonic acid, methyl ester. potassium salt 3S trans 3 1,1 dimethylethoxy carbonyl amino 4 methyl 2 oxo 1 azetidinyl oxy methyl phosphonic acid, methyl ester. potassium salt 70 mg, 0.19 mmol was dissolved in a solution of 10 anisole in trifluoroacetic acid 2 ml at 10 C. The solution was stirred for thirty minutes and the volatiles removed at room temperature on a vacuum pump for three hours. to give the crude trifluoroacetic acid salt of the starting azetidinone. Activated Z 2 amino methoxyimino 4 thiasoleacetic acid was prepared by dissolving the acid 40 mg. 0.20 mmol and hydroxybenzotriazole 27 mg. 0.20 mmol in dimethylformamide 1 ml . After cooling the solution to 10 C. dicyclohexylcarbodiimide 45 mg, 0.22 mmol was added and the ice bath removed. Stirring was continued for 90 minutes. after which the solution was recooled to 100C. and the crude trifluoroacetic acid salt prepared above. was added in dimethylformamide 1 ml . followed by two rinses of dimethylformamide 1 ml. 0.5 ml . To this solution was added triethylamine 120 1, 0.86 mmol .The solution was found to be basic by pH paper. the cooling bath was removed and the solution stirred overnight at room temperature. Dimethylformamide was removed from the reaction mixture in vacuo, and the resulting product treated with water 1.5 ml to afford a slurry of pH 4. Potassium bicarbonate was added to adjust the pH to 8.5. and the material was chromatographed on Dowex K resin 200 400 mesh.25 mi x 6 . Lyophilization of the fractions containing W active material afforded 0.70 g of product. This material was further purified by chromatography on HP 20 resin 25 mm x 8 .Lyophilization of the appropriate fractions afforded 30 mg of the title compound. Analysis of the spectral data for this material indicated contamination of the product by hydroxybenzo triazole and dicyclohexylurea. The product browned at 164 C and decomposed at 210 C. ExamPle 3 3S 3 alpha Z ,4ss 3 2 Amino 4 thiazolyl methoxyimino acetyl amino 4 methyl 2 oxo 1azetidinyl oxy methyl methylphosphinic acid.potassium saltA Hydroxymethylamethylphosphinic acid, ethyl ester Ethyl methylphosphinate 9.41 g, .087 mole was heated to 850C under nitrogen. Dried paraformaldehyde 2.61 g, .078 mole was added. and the reaction mixture was heated at 85 950C for 5 minutes and then at 780C for 2 hours. The product was distilled at 1280C 0.9mm to yield 7.92 g of the title compound. B Trifluoromethyl sulfonyl sulfonyl oxy methyl methyl ahosPhinic acid. ethyl ester A solution of dichloromethane 2 ml .pyridine 0.23 ml. 2.65 mmole . and hydroxymethyl methylphosphinic acid, ethyl ester 0.37 g, 2.65 mmole was added dropwise to triluoformethanesulfonic anhydride 2.65 mmole. 0.45 ml in 2 ml of dry dichloromethane at 10 C under nitrogen. The reaction was stirred for 20 minutes at 100C, diluted with 20 ml of dichloromethane and washed twice with 5 ml portions of water. The organic layer was dried sodium sulfate and concentrated in vacuo to yield 0.16 g of the title compound. C 3S 3 alpha ,4ss 3 1,1 Dimethylethoxycarbonyl amino 4 methyl 2 oxo 1 azetidinyl oxy methyl methylphosphinic acid, ethyl ester A solution of 3S 3 alpha , 4ss 3 2,2dimethylethoxycarbonyl0amino 4 methyl 2 oxo 1hydroxyazetidine 0.155 g, 0.62 mmole and triethylamine 0.11 ml, 0.77 mmole in dimethylformamide 1 ml was added to trifluoromethyl0sulfonyl oxy methylphosphinic acid, ethyl ester 0.21 g. .77 mmole at 10 C under nitrogen. The reaction was stirred at 00C for 1 hour and then concentrated in vacuo. The residue was dissolved in dry dichloromethane and washed successively with pH 5.5 0.5M KH2PO4. pH 3.0 KH2PO4 buffer. and water. It was then dried sodium sulfate and concentrated in vacuo to yield 0.175 g of crystalline product. melting point 84 890C. D 3S 3 alpha ,4ss 3 1,1 Dimethylethoxycarbonyl amino 4 methyl 2 oxo 1 azetidinyl oxy methyl methylphosphinic acid, potassium salt 3S 3 alpha ,4ss 3 1,1 Dimethylethoxycarbonyl amino 4 methyl 2 oxo 1 azetidinyl oxyjmethyl3methylphosphinic acid. ethyl ester 0.175 g. 0.52 mmole was dissolved in 1.5 ml of dry dichloromethane and cooled to 10 C under nitrogen. Bistrimethylsilylacetamide BSA, 1.25 ml. 3.9 mmole was added, and the reaction was stirred for 30 minutes at 0 C. Trimethylsilylbromide TMSBr, O.17 ml, 1.3 mmole was added. and the reaction was stirred at ambient temperature for 2 hours.The reaction mixture was concentrated in vacuo, and the residue was evaporated twice from toluene. The residue was dissolved in 2 ml of tetrahydrofuran and 2 ml of 0.5M KH2PO4 pH 5.5 buffer and stirred at room temperature for 1 hour at pH 5. The tetrahydrofuran was removed in vacuo and the crude aqueous solution was washed with dichloromethane. The dichloromethane solution was concentrated in vacuo to yield 77 mg of azetidinyl phosphinate starting material, and the aqueous layer was chromatographed on 60 ml of HP 20 with water and then with 10 acetone water. The appropriate fractions were combined and lyophilized to yield 52 mg of the title compound as a solid.E 3S 3 alpha ,4ss 3 Amino 4 methyl 2 oxo 1 azetidinyl oxy methyl methylphosphinic acid. trifluoroacetic acid salt 3S 3 alpha ,4ss 3 1,1 Dimethylethoxycarbonyl amino 4 methyl 2 oxo 1 azetidinyl oxy methyl methylphosphinic acid. potassium salt 50 mg. 0.15 mmole was suspended in 0.5 ml of dichloromethane and 0,5 ml of anisole at 0 C under nitrogen, Trifluoroacetic acid 1.0 ml was added, and the reaction was stirred at 0 C for 2 hours.The solution was concentrated in vacuo to a residue. which was evaporated twice from toluene to give a viscous oil This was triturated with ether to give a white solid. The NMR spectrum of this solid in D2 0 was consistent with that expected fpr the product. The D20 solution was concentrated in vacuo to dryness and used in thefollowing step. F 3S 3 alpha Z ,4ss 3 2 Amino 4 thiazolyl methoxyimino acetyl amino 4 methyl 2 oxo 1 azetidinyl oxy methyl methylphosphinic acid. potassium salt. Z 2 Amino alpha methoxyimino 4 thiazoleacetic acid 30.9 mg, 0.15 mmole and l hydroxybenzo triazole 23.2 mg. 0.15 mmole were dissolved in 1 ml of dimethylformamide at 0 C under nitrogen.N.N Dicyclohexylcarbodiimide DCC, 31.2 mg, 0.15 mmole was added. and the reaction was stirred at 0 C for 2 hours. 3S 3 alpha , 4ss 3 Amino 4 methyl2 oxo 1 azetidinyl oxy methyl methylphosphinic acid. trifluoroacetic acid salt was dissolved in 3 ml of pH 5.5 0.5M KH2PO4 buffer. and the pH was adjusted to 5.5 with 1M potassium hydroxide. This was added to the activated ester. and the reaction was stirred at ambient temperature overnight. The reaction mixture was filtered and concentrated in vacuo. The residue was washed with dichloromethane, dissolved in water. and passed through 10 ml of Dowex 50K resin 0.7 m eq ml .Fractions 4ml were collected, and the appropriate fractions were combined and lyophilized to a residue. which was chromatographed through 30 ml ofHP 20 using water to elute the product. After lyophilization. 21 mg of desired product was obtained. melting point 192 202 C. dec. Example 4 2S 2 alpha ,3ss Z 3 2 Amino 4 thiazolyl methoxyimino acetyl amino 2 methyl 4 oxo 1 azetidinyl oxy methyl phosphonic acid, 2 amino 2 oxoethyl ester, monopotassium saltA Hydroxy methyl phosphonic acid, dimethyl ester Dimethyl phosphite 12.02 g, .11 mole and triethylamine 1.0 g, .01 mole were heated to 400C under N2.Paraformaldehyde 3.28 g, .11 mole was added portionwise and the reaction mixture was heated up to 550C.Immediate reaction occurred, and a clear solution was formed. After reaction subsided, heating was continued at 550C for 15 minutes. The crude reaction mixture was used as is in step B. B Trifluoromethyl sulfonyl oxy methyl phosphonic acid, dimethyl ester l Hydroxy methyl phosphonic acid, dimethyl ester 2.10 g, 15 mmole was dissolved in 3 ml of dry CH2C12 and cooled to 600C. Triethylamine 1.52 g, 15 ininole was added followed by the slow dropwise addition of trifluoromethanesulfonic anhydride 4.23 g, 15 mmole .The reaction was stirred until the temperature reached 250C., CH2C12 10 ml was added, and the reaction mixture was washed with two 5 ml portions of cold water.The dichloromethane solution was dried with Na2S04, and concentrated in vacuo to yield 3.0 g 83 of the triflate ester. C 2S 2 alpha ,3ss 1,1 dimethylethoxy carbonyl amino 2 methyl 4 oxo 1 azetidinyl oxy methyl phosphonic acid, dimethyl ester The above triflate 2.2 g, 8.1 rurnole was added dropwise to a solution of 12S 2a,38 3 If l,l dimethyl ethoxy carbonyl amino 2 methyl 4 oxo 1 hydroxyazetidine 1.77 g, 8.2 mmole and triethylamine 1.28 ml, 8.1 mmole in 5 ml DMF at 10 C. The reaction was stirred under N2 at 100C for 4 hrs. and then concentrated in vacuo. The residue was dissolved in dry dichloromethane 150 ml and washed successively with pH 5.5 0.5 M KH2PO4, Ph 3.0 KH2PO4, and water. It was then dried Na2S04 and concentrated in vacuo to a volume of 4 ml.This was placed on 50 ml of SilicARCC 7 and then filtered through with 400 ml CH2Cl2. The filtrate was concentrated to yield 1.59 g 57 of crystalline product having M.P. 51 55 C. D 2S 2 alpha ,3ss 3 1,1 Dimethylethoxy carbonyl amino 2 methyl 4 oxo l azetidinyl 1 oxy methyl phosphonic acid, monomethyl ester, monopotassium salt The above azetidinyl phosphonate 1.08 g, 3.2 imnole and thiourea 0.24 g, 3.2 mmole were refluxed in 2 ml of dry acetonitrile under N2 overnight. The solution was cooled, and the crude thiuronium salt of the product oiled out. The supernatant was decanted, and the residue was dissolved in water and passed through 70 ml of Dowex 50 in K form 0.7 meq ml . The product was chromatographed on 100 ml of HP 20 with water and then with 10t acetone water. The appropriate fractions were combined and lyophilized to yield 0.53 g 48 of product as the potassium salt. E 2S 2 alpha ,3ss 3 1,1 Dimethylethoxy carbonyl amino 2 methyl 4 oxo l azetidinyl oxy methyllphosphonic acid, 2, amino 2 oxoethyl ester, monopotassium salt The above monomethyl ester, potassium salt 0.5 g, 1.4 mmole was ion paired with tetrabutylammonium sulfate 0.14 ml of 0.1 M in pH 5.5 buffer . Product was extracted with six 50 ml portions of CH2C12, dried and concentrated in vacuo to yield 0.85 g of tetrabutylammonium salt. This was dissolved in 4 my of 1,1, l trichloroethane. Iodoacetamide 0.57 g, 3.1 mmole was added, and the reaction mixture was refluxed under nitrogen for 6 hrs. Volatiles were evaporated in vacuo, and the residue was passed through 50 ml of Dowex 50 2X400 .7 meq ml in the K form.The eluent was lyophilized and chromatographed on 70 ml ofHP 20 with water and then 5 acetone water to yield upon lyophilization 0.10 g 16 of desired product. F 2S 2 alpha ,3ss 3 Amino 2 methyl 4 oxo 1 azetidinyl oxy3methyl phosphonic acid, mono 2 amino 2 oxoethyl ester, trifluoroacetic acid salt The above azetidinyl phosphonic acid, potassium salt 82 mg, .20 mmole was suspended in 0.2 ml ofCH2C12 and 0.2 ml of anisole at 100C under N2.Trifluoroacetic acid 0.4 ml was added, and the reaction was stirred at 0 C for 1.5 hrs. The solution was concentrated in vacua to a residue, which was evaporated from benzene 2X to give a viscous oil.This was triturated with ether to give crude desired product as a white solid. G. 2S 2 alpha ,3ss Z 3 2 Amino 4 thia zolyl methoxyimino acetyl3amino 2 methyl 4 oxo 1 azetidinyl oxy methyl phosphonic acid, 2 amino 2 oxoethyl ester, monopotassium salt Z 2 Amino 4 thiazolyl methoxyimino acetic acid 40.8 mg, .20 mmole and l hydroxybenzotriazole 31.1 mg, 0.20 mmole were dissolved in 0.4 ml ofDMF at 0 C under N2. N,NÚ Dicyclohexsylcarbodiimide DCC, 41.9 mg, 0.29 mmole was added, and the reaction was stirred at 0 C for 2 hrs. The above crude TFA salt was dissolved in 2 ml of pH 5.5 0.5 M KH2PO4 buffer, and the pH was adjusted to 6.0 with 1 N KOH. This was added to the activated ester, and the reaction was stirred at ambient temperature overnight. The react ion mixture was filtered and concentrated in vacuo.The residue was dissolved in water and passed through 80 ml of Dowex 50K resin 0.7 meq ml . Five ml fractions were collected, and the appropriate fractions were combined and lyophilized to a residue, which was chromatographed through 80 ml of HP 20 using water to elute the product. After lyophilization, 19 mg 19 of desired product was obtained having m.p. 165 175 dec.Anal. Calc d. for C13H18N608SPK 2. 9H20 C,28.87 H,4.44 N,15.54 S,5.90 P,5.70 Found C,29.27 H,3.79 N,14.13 S,5.60 P,5.30 Example 5 2S 2 alpha ,3ss 1 3 Amino 2 methyl 4 oxo 1 azetidinyl oxy ethyl phosphonic acid, monomethyl ester, trifluoroacetic acid salt A. ll Hydroxyethyl phosphonic acid, dimethyl ester Dimethyl phosphite 2.34 g, 0.021 mole acetaldehyde 0.89 g, .020 mole and potassium fluoride 1.90 g, .020 mole was stirred at 0 C for 2 hrs. under N2. The reaction mixture was then diluted with 50 ml of CH2C12 and filtered to remove potassium fluoride, The filtrate was concentrated in vacuo to yield 3.02 g 98 of product. B. C1 CI TrifluoromethyI sulfonyl oxy ethyl phosphonic acid, dimethyl ester fl Hydroxyethyljphosphonic acid, dimethyl ester 2.11 g, 13,7 mmole was dissolved in 3 ml of dryCH2C12 and cooled to 40 C under N2. Triethylamine 1.39 g, 13.7 mmole was added, followed by the slow dropwise addition of trifluoromethanesulfonic anhydride 3.87 g, 13.7 mmole . Stirring was continued until the reaction temperature reached 25 C. Dichloromethane 20 ml was added and washed with two 4 ml portions of water. The CH2C12 solution was dried Na2SO4 and concentrated in vacuo to yield 3.62 g 92 of desired triflate. C. 2S 2 alpha ,3ss 1 3 1,1 Dimethylethoxy carbonyl0amino 2 methyl 4 oxo 1 azetidinyl oxy ethyl phosphonic acid, dimethyl ester The above triflate ester 2.68 g, 94 mmole was added dropwise in two portions 30 minutes apart at 10 C under N2, to a 4 ml DMF solution of 12S 2a,3ss 3 1,1 dimethylethoxycarbonyl amino 2 methyl 4 oXo 1 hydroxyazetidine 1.35 g, 6.3 mmole see SQ 28,085 and triethylamine 1.3 ml, 9.5 mmole . The solution was stirred at ambient temperature for 1 hr. then concentrated in vacuo. The residue was dissolved in dry CH2C12 and washed successively with pH 2.8 0.5 M RH2P04, pH 5.5 KH2P04 buffer and water.The CH2C12 was dried tNa2SO4 and concentrated in vacuo to yield 2.4 g theory of product as a light yellow oil. D. 2S 2 alpha ,3ss 3 1,1 Dimethylethoxy carbonyl amino 2 methyl 4 oxo 1 azetidinyl oxy ethyl phosphonic acid, monomethyl ester, monopotassium salt The above azetidinyl phosphonate 1.35 g, 3.8 mmole and thiourea 0.58 g, 7.7 mmole were dissolved in 1 ml dry acetonitrile and refluxed under N2 for 6 hrs. The reaction mixture was cooled and diluted with 2 ml of ether. The thiuronium salt of the product oiled out and was dissolved in 2 ml of water. This solution was passed through 100 ml of Dowex 50 resin 0.7 meq ml . Twenty ml fractions were collected, and the appropriate ones were combined and lyophilized to a residue, which was chromatographed through 100 ml of HP 20 using water.After lyophilization of the appropriate fractions, 0.89 g 68 of desired product was obtained. E. 2S 2 alpha ,3ss 1 3 Amino 2 methyl 4 oxo 1 azetidinyl oxylethylIphosphonic acid, mono methyl ester, trifluoroacetic acid salt The above azetidinyl phosphonic acid, monomethyl ester, potassium salt 0.34 g, 0.9 mmole was suspended in 3 ml of CH2C12 and 3 ml of anisole at 100C under N2. Trifluoroacetic acid 6 ml was added, and the reaction was stirred at 0 C for 2 hrs. The solution was concentrated in vacuo to a residue, which was evaporated from benzene. This was triturated with ether and dried in vacuo to give a white solid. F. 2S 12a,3ss Z l t 3 2 Amino 4 thiazolyl methoxyimino acetyl amino 2 methyl 4 oxo 1 azetidinylAoxy ethyl phosphonic acid, monomethyl ester, mono potassium salt Z 2 Amino 4 thiazolyl methoxyimino acetic acid 183 mg, 0.92 mmole and l hydroxybenzotriazole 139 mg, 0.92 mmole were dissolved in 1.2 ml of DMF at 0 C under N2 . N,N1 Dicyclohexylcarbodiimide DCC, 188 mg, 0.92 mmole was added, and the reaction was stirrediat 0 C for 2 hrs. The above crude TFA salt was dissolved in 4 ml of pH 5.5 0.5 M KH2PO4 buffer. This was added to the activated ester, and the pH was adjusted to 4.6 with 1 M KOH.The reaction was stirred at ambient temperature overnight, filtered and concentrated in vacuo. Hydroxybenzotriazole precipitated out of the reaction mixture upon addition of ice water 5 ml pH 4.3 and was filtered The filtrate was chromatographed through 150 ml of HP 20. Product was eluted with 5 acetone in water to yield 117 mg of desired material in the acid form after lyophilization.This was redissolved in 2 ml 0.5 M KH2PO4 buffer, and the pH was adjusted to 4.9 with 1 N KOH.This was rechromatographed through 80 ml ofHP 20. The potassium salt eluted with water and was lyophilized to yield 91 mg 30 of desired material having a m.p. 182 2004C. Calc d. for C13H19N5O7PSK.1.77H2O C,31.78, H,4.62 N,14.25 S,6.53 P.6.30 Found C,31.78 H,4.34 N,14.12 S,6.61 P,6.2 Example 6 3S 3 alpha Z ,4ss 3 2 amino 4 thiazolyl 1 diphenylmethoxycarbonyl 1 methylthoxy imino acetyl amino 4 methyl 2 oxo 1 azetidinyl oxy methyl phosphonic acid, diethyl ester By substituting Z 2 amino alpha 1 diphenyl methoxycarbonyl 1 methylethoxy imino 4 thiazoleacetic acid for the Z 2 amino alpha methoxyimino 4 thiazoleacetic acid used in example cf , the above titled compound is obtained.